Two years later, the patient experienced ICD shocks due to VF triggered by emotional stress. She was offered bilateral cardiac sympathetic denervation (CSD), which had not yet been per formed in Poland in adults for arrhythmic indi cations. The patient was referred to a regional thoracic surgery center experienced in video assisted thoracoscopic CSD in hyperhidrosis and Raynaud disease. Although left CSD was considered, recent studies and persistent cold ness in the upper extremities supported the use of a bilateral approach.
2 Bilateral CSD was per formed within 60 minutes with a single port access for each site from the third intercostal space in the medial axillary line. Sympathetic ganglia and fibers were removed from the level of Th1 to Th5, with the upper level of right sided dissection marked with a titanium clip used for bleeding prevention (FIGURE 1B). The results were confirmed histologically (FIGURE 1C). Interesting ly, the patient reported an immediate change in temperature perception, allowing her to stop wearing gloves at temperatures below 10°C de spite continued β blocker therapy. There were no ICD interventions during the 6month follow up.
Our case demonstrates several pitfalls of CPVT management. First, the CPVT diagnosis was delayed owing to incomplete workup dur ing the initial hospitalization. The exercise test was only performed at follow up to confirm an tiarrhythmic efficacy of metoprolol. 1 Secondly, whereas in the largest pediatric CPVT registry, flecainide and CSD were used in 24% and 8% of patients, respectively, 3 nadolol and flecainide
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare inherited disease linked to syncope, bidirectional or polymorphic ventricular tachycardia (bidVT/pVT), ventricu lar fibrillation (VF), and sudden cardiac death during exercise or emotional stress in patients without organic heart disease. 1 There are sever al diagnostic and therapeutic options, although their availability in different countries is limited.
We present a case of a 30year old white wom an after aborted cardiac arrest, which occurred at her brother's funeral. During hospitaliza tion, bidVT/pVT and VF reoccurred, requiring 5 defibrillations. Serial electrocardiograms re vealed no features of short QT, long QT, or Bru gada syndrome, whereas telemetry and Holt er recordings documented bidVT/pVT runs (FIG-URE 1A ). Echocardiography and coronary angiogra phy were normal.
A single chamber ProMRI® implantable cardioverter defibrillator (ICD; Iforia 5 VR T, Biotronik, Berlin, Germany) was implanted, and the patient was discharged on metoprolol (50 mg twice daily) with recommendations for genetic and family screening. Until now, only her 6year old daughter was screened (no ab normalities were detected), as no other family members agreed to be screened. Genetic test ing is still underway due to lack of reimburse ment. Although a follow up exercise test re vealed no significant arrhythmia, the patient still complained of cold sensation in the up per extremities, which she linked to meto prolol use.
are not widely available in Poland. Moreover, the largest Polish registry of patients with long QT syndrome reported no cases of CSD.
4 The lim ited access to subcutaneous ICDs, genetic test ing, flecainide, and nadolol affects the quality of care in patients with CPVT and other inherit ed arrhythmogenic diseases. Although rare pre scription drugs can be imported (so called tar get import), administrative barriers limit their availability in clinical practice.
To the best of our knowledge, this is the first case of bilateral CSD in an adult with CPVT in Poland. Despite diagnostic and therapeutic chal lenges, the patient was diagnosed and managed as part of a multicenter interdisciplinary heart team including specialists in electrophysiology, inher ited arrhythmias, and cardiothoracic surgery. 
